This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| AUTO TRADER GROUP PLC | 595.6 | 3.4% |
| HARGREAVES LANSDOWN PLC | 1,831.5 | 3.1% |
| WM MORRISON SUPERMARKETS | 187.7 | 3.0% |
| RENTOKIL INITIAL PLC | 481.4 | 3.0% |
| EXPERIAN PLC | 2,693.0 | 2.9% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| NMC HEALTH PLC | 1347.5 | -4.1% |
| JUST EAT PLC | 865.6 | -1.7% |
| WHITBREAD PLC | 4302.0 | -1.2% |
| ITV PLC | 141.0 | -0.8% |
| CARNIVAL PLC | 3428.0 | -0.8% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 7,586 | 1.0% | 11.4% |
| DOW JONES INDUS. AVG | 28,990 | -0.6% | 17.2% |
| DAX INDEX | 13,577 | 1.4% | 20.3% |
| NIKKEI 225 | 23,344 | -2.0% | 12.4% |
| S&P/ASX 200 INDEX | 7,091 | 0.0% | 20.1% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 52.94 | -2.31% |
| Brent Crude (ICE) | USD/bbl. | 59.37 | -2.17% |
| Gold Spot | USD/t oz. | 1,578 | 0.4% |
| Copper (Comex) | USd/lb. | 264 | -1.7% |
Click graph to enlarge
UK 100 called to open -100 points at 7490; Deepening fears about the economic and human impact of the deadly coronavirus sent stocks, crude oil and China’s yuan tumbling Monday, and spurred haven assets higher. Futures on Chinese shares fell more than 5% and the yuan erased this month’s trade-deal driven gains in wake of news that the virus continues to spread, with no peak in sight. The Nikkei fell by 2% (483 points) to close at 23,343, however the Hang Seng pared early losses to close the session +40 points at 27,949. The US closed out last week with an all red trading session, led lower by the Dow Jones, dropping 170 points to close at 28,989, the S&P saw a similar percentage fall, giving up 30 points to close at 3,295 and the nasdaq completed the red set, closing at 9,314 (-87 points). Crude oil slipped elow $60 a barrel overnight, whilst traditional safe haven gold rallied to $1578 per troy ounce.
AstraZeneca divests rights to established hypertension medicines. The sale of Inderal, Tenormin, Tenoretic, Zestril and Zestoretic to Atnahs Pharma supports AstraZeneca's strategy of focusing on pipeline of new medicines.
AstraZeneca also announces that it is to recover the global rights to brazikumab from Allergan.
Funding Circle announce that Oliver White is to succeed Sean Glithero as CFO later this year.
Halma announces two acquisitions for its medical and infrastructure safety sectors. They have acquired NovaBone products (£74m) and FireMate Software Pty (£9.5m based on performance).
Petra Diamonds H1 revenue -6% ($193.9m) from 1,743,807 carats sold. Production +3% to 2,070,240 carats. They are currently on track to meet or exceed FY 2020 production guidance of 3.8m carats.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Sthree, ITM Power, Petra Diamonds,
Crest Nicholson, Unilever, McCarthy, Haynes, PZ Cussons, Rank, Barr (A.G.), Renishawm, UDG Healthcare, Royal Dutch Shell, Hargreaves Lansdown, Evraz, BT Group, Diageo
German Consumer Confidence
US New Home Sales
UK 100 :
None
:
IG Group
Victrex
Ashtead Downgraded to Hold by Peel Hunt (Bloomberg: 12 Buys/ 6 Holds/ 0 Sells)
Babcock Upgraded to Add by Peel Hunt (Bloomberg: 5 Buys/ 6 Holds/ 2 Sells)
Bunzl Downgraded to Sell by Peel Hunt (Bloomberg: 7 Buys/ 3 Holds/ 6 Sells)
Burberry Downgraded to Hold by MainFirst (Bloomberg: 2 Buys/ 14 Holds/ 6 Sells)
Computercenter Upgraded to Buy by Berenberg (Bloomberg: 4 Buys/ 1 Holds/ 1 Sells)
DCC Upgraded to Buy by Peel Hunt (Bloomberg: 12 Buys/ 2 Holds/ 0 Sells)
Just Eat Upgraded to Overweight by Barclays (Bloomberg: 6 Buys/ 8 Holds/ 3 Sells)
Lloyds Downgraded to Neutral by Mediobanca (Bloomberg: 6 Buys/ 8 Holds/ 3 Sells)
Serco Downgraded to Hold by Peel Hunt (Bloomberg: 9 Buys/ 3 Holds/ 0 Sells)
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.